SCHEMBL19612759

SCHEMBL19612759

CCCCC(C(=O)Cl)c1ccc2ccccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UGT2B7 P16662 1/20 0.44
PPARG P37231 2/20 0.43
PPARA Q07869 2/20 0.43
MMP1 P03956 1/20 0.43
MMP7 P09237 1/20 0.43
ACE P12821 1/20 0.43
MMP12 P39900 1/20 0.43
MMP13 P45452 1/20 0.43
HDAC1 Q13547 2/20 0.43
HDAC8 Q9BY41 1/20 0.43
NPC1 O15118 1/20 0.43
LMNA P02545 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
AKR1C3 P42330 4/20 0.42
AKR1C2 P52895 4/20 0.42
HDAC3 O15379 1/20 0.42
HDAC2 Q92769 1/20 0.42
CETP P11597 1/20 0.41
MMP9 P14780 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9062912 0.94 HDAC1 (0.47) UGT2B7PPARGPPARAMMP1MMP7
SCHEMBL7799567 0.87 AKR1C3 (0.52) UGT2B7PPARGPPARAMMP1MMP7
SCHEMBL19612582 0.85 AKR1C3 (0.35) LMNAAKR1C3AKR1C2AKR1C1PTGS1
SCHEMBL11321098 0.82 AKR1C3 (0.51) UGT2B7PPARGPPARAHDAC1HDAC8
SCHEMBL2545036 0.81 AKR1C3 (0.50) UGT2B7PPARGPPARAHDAC1HDAC8
SCHEMBL11319751 0.81 AKR1C3 (0.50) UGT2B7PPARGPPARAHDAC1HDAC8
SCHEMBL2536993 0.81 AKR1C3 (0.50) UGT2B7PPARGPPARAHDAC1HDAC8
SCHEMBL11316020 0.81 AKR1C3 (0.50) UGT2B7PPARGPPARAHDAC1HDAC8
SCHEMBL19612626 0.81 POLB (0.50) LMNA
SCHEMBL19612577 0.79 IAPP (0.41) LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10174015-B2 Substituted heterocyclic derivative, preparation method and use thereof XIAMEN UNIVERSITY (CN) 2019-01-08 US disclosed
US-20170334896-A1 Substituted Heterocyclic Derivative, Preparation Method And Use Thereof XIAMEN UNIVERSITY (CN) 2017-11-23 US disclosed
CN-107074788-A Substituted heterocyclic derivatives, preparation method and application thereof 厦门大学 2017-08-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334896-A1 Substituted Heterocyclic Derivative, Preparation Method And Use Thereof FAAH, NAAA, FAAH2 UGT2B7 255/4885PPARG 1302/4885PPARA 792/4885
US-10174015-B2 Substituted heterocyclic derivative, preparation method and use thereof DHPS, CYP3A5, CYP3A4 UGT2B7 32/4885PPARG 900/4885PPARA 864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.